Calyxt Achieves Phase 1 Milestone in Collaboration Agreement to Develop Alternative to Palm Oil

/PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biology company announced today that it has successfully completed the first phase in its...

Related Keywords

Cameron Willis ,Brennan Burks ,Kimberly Minarovich ,Michaela Carr ,Calyxt Inc ,Nasdaq ,Plant Cell ,Securities Litigation Reform Act ,Annual Report ,Media Contact ,Investor Relations Contact ,Calyxt ,Nc ,